SSBP4 inhibitors are a class of chemical compounds specifically designed to target and inhibit the activity of SSBP4 (Single-Stranded DNA-Binding Protein 4), a protein that plays a key role in DNA metabolism, particularly in processes such as DNA replication, repair, and recombination. SSBP4 is part of a family of single-stranded DNA-binding proteins that stabilize single-stranded DNA (ssDNA) intermediates during critical cellular processes. By binding to ssDNA, SSBP4 helps prevent the formation of secondary structures that could interfere with the proper progression of replication or repair pathways. It also assists in maintaining genomic stability by protecting ssDNA regions during replication or in response to DNA damage. Inhibitors of SSBP4 function by disrupting its interaction with ssDNA, potentially leading to altered DNA metabolism and impacting essential cellular processes.
The mechanism of action of SSBP4 inhibitors typically involves direct binding to the protein's ssDNA-binding domain, preventing SSBP4 from stabilizing ssDNA during replication or repair. Some inhibitors may block the protein's ability to interact with DNA by competing with ssDNA for binding, while others might induce conformational changes in SSBP4 that reduce its affinity for DNA or interfere with its ability to participate in DNA metabolism. By inhibiting SSBP4, these compounds can disrupt key processes such as DNA replication and repair, leading to genomic instability and affecting cell cycle progression. Research into SSBP4 inhibitors provides valuable insights into the molecular mechanisms governing DNA replication and repair, highlighting the critical role that ssDNA-binding proteins play in maintaining genome integrity. Understanding how SSBP4 regulates DNA metabolism also offers broader insights into the coordination of replication, repair, and recombination processes in eukaryotic cells.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
As a DNA methyltransferase inhibitor, 5-Azacytidine can demethylate promoter regions, potentially leading to the downregulation of genes including SSBP4. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
This compound inhibits histone deacetylases, leading to an increase in acetylated histones and a subsequent decrease in transcription of certain genes, possibly including SSBP4. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium Butyrate inhibits histone deacetylase, enhancing histone acetylation and potentially leading to reduced transcriptional activity of mitochondrial genes like SSBP4. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
By activating sirtuin pathways, Resveratrol may lead to changes in gene expression that result in the decreased expression of mitochondrial proteins such as SSBP4. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $79.00 | 2 | |
Metformin disrupts the mitochondrial respiratory chain, which could result in decreased mitochondrial biogenesis and lower expression of related proteins including SSBP4. | ||||||
Rotenone | 83-79-4 | sc-203242 sc-203242A | 1 g 5 g | $89.00 $259.00 | 41 | |
By inhibiting the mitochondrial electron transport chain, Rotenone can lead to reduced mitochondrial function and potentially lower levels of SSBP4 expression. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Doxorubicin induces oxidative stress within mitochondria, potentially leading to decreased synthesis or stability of mitochondrial proteins such as SSBP4. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
As a DNA intercalating agent, Actinomycin D can inhibit RNA synthesis, potentially leading to decreased levels of mitochondrial transcripts including SSBP4. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin suppresses mTOR signaling, which is crucial for protein synthesis and cell growth, potentially resulting in decreased expression of proteins like SSBP4. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine accumulates in mitochondria and disrupts their function, which could lead to reduced levels of mitochondrial proteins including SSBP4. | ||||||